• Most Popular
  • Most Shared

Labopharm requests U.S. FDA meeting about tramadol

Mon Sep 24, 2007 4:47pm EDT

Stocks

   

TORONTO, Sept 24 (Reuters) - Labopharm Inc (DDS.TO) (DDSS.O) said on Monday it has requested a meeting with the U.S. Food and Drug Administration regarding regulatory approval for its once-daily formulation of the painkiller tramadol .

Regulatory News

The company said that based on its analysis and discussions with its regulatory advisors, it believes that it has "demonstrated the efficacy and safety" of its tramadol formulation.



More from Reuters

A customer is served at a counter inside a foreign exchange store displaying a poster of various banknotes including the Chinese yuan or renminbi (RMB) in Hong Kong November 20, 2009. REUTERS/Bobby Yip
OUTLOOK 2010:

Be careful what you wish for

Pressure on China to loosen its grip on the yuan will continue but the U.S. should tread carefully. Here are five world market issues to watch.  Full Article 

Aurora, a 20-year-old Beluga whale, swims with her newborn calf after giving birth at the Vancouver Aquarium in Vancouver, British Columbia June 7, 2009. REUTERS/Andy Clark

365 days for the doomed

From polar bears to emperor penguins, endangered species will get top online billing in 2010 during the Year of Biodiversity.  Full Article